Patenting psychedelic medicines, Research conducted on psilocybin therapy's durability, Can psilocybin become a legitimate mental health treatment?
PSYCH Symposium: London 2022 - Europe's premier psychedelic medicine conference, Oregon releases draft rules for psilocybin framework, Mindstate Design Labs raises US$11.5m
Cybin on converting psychedelic molecules; Psychedelic medicines offer treatment for eating disorders; Oregon proposes ban on synthetic psilocybin
Psychedelic profiles: LSD, Should psychedelics be more widely available? Virginia decriminalisation bill defeated in Senate committee hearing.
Psychedelic profiles: ibogaine; Eleusis goes public via merger, creating a US$450 million company; The future of psychedelic medicine will be drugs you’ve never heard of.
Psychedelic profiles: ketamine; Italian officials certify signatures for psilocybin referendum; Sixty-five per cent of Americans with mental health conditions want access to psychedelics.
Psychedelic profiles: psilocybin; Awakn releases data from Phase II study for alcohol use disorder; Canada amends Special Access Program for psychedelic medicines.
Psychedelic profiles: MDMA; The promises and perils of psychedelic healthcare; Psychedelic drug firm gets rare endorsement from big pharma.
Psychedelic healthcare in 2021; Ketamine for the treatment of mental health disorders; Ketamine therapy is going mainstream, are we ready?
Gwella on making microdosing mainstream; The MHRA releases new guidance on using data in clinical trials; Psychedelics: the newest tool in nuclear negotiations?
Healthcare professionals’ perception of psychedelic medicines; Australian regulator refuses to reclassify psychedelic compounds; COMPASS shares further data from COMP360 Phase IIb trial
Is the NHS ready to embrace psychedelics as medicine?; DEA again boosts 2022 production goals for psychedelic medicines; MAPS and Vine Ventures raise US$70m through revenue sharing model
Join over 25,000 investors, academics and operators who receive the latest news on the psychedelic science and healthcare industry. Straight to your inbox once a week.